Food and Drug Administration approved its oral glucagonlike peptide 1 (GLP-1) medication for weight loss and obesity in adults
Plasma thiol levels were quantified using Ellman's reagent (5,5-dithio-bis-2-nitrobenzoic acid, DTNB)
When evaluating ipamorelin vs sermorelin, ipamorelin provides a cleaner GH pulse
Improved Liver Health Fatty liver disease can be caused by not having enough antioxidants, like glutathione
In January 2026, the FDA issued a warning letter to a 503A compounding pharmacy specifically for GLP-1 product violations involving insanitary conditions and strength, quality, and purity noncompliance
Following a recent surge in vision-loss claims, the FDA is intensifying its focus on NAION